Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
119
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

Ainhoa Arenaza1 Pharmacy Department, Clínico San Carlos Hospital, Madrid, Spain
,
Raúl Diez2 Pharmacy Department, University De Getafe Hospital, Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-9627-5337
ORCID Icon,
Jordi Esteve3 Hematology Department, Clinic Hospital, Barcelona, Spain
,
Roberta Di Nicolantonio4 Health Economics and Outcome Research, Novartis Farmacéutica S.A., Madrid, Spain
,
Joana Gostkorzewicz4 Health Economics and Outcome Research, Novartis Farmacéutica S.A., Madrid, Spain
,
Carlos Martínez5 Pharmacy Department, University Hospital Araba, Vitoria, SpainORCID Iconhttps://orcid.org/0000-0002-0802-3181
ORCID Icon,
Diana Martínez Llinàs6 Oblikue Consulting, S.L., Barcelona, SpainCorrespondence[email protected]
,
Joaquin Martinez-Lopez7 Hematology Department, University Hospital 12 de Octubre, CNIO, Complutense University, Madrid, SpainORCID Iconhttps://orcid.org/0000-0001-7908-0063
ORCID Icon,
Pau Montesinos8 Hematology Department, University Hospital La Fe, Valencia, & CIBERONC, Instituto Carlos III, Madrid, Spain
,
Aída Moure-Fernández6 Oblikue Consulting, S.L., Barcelona, Spain
,
Jorge Sierra9 Hematology Department, University Hospital Santa Creu i Sant Pau, Barcelona, Spain
&
Joan Lluís Vinent10 Pharmacy Department, Sant Joan de Déu Hospital, Barcelona, Spain
 show all
Pages 683-694 | Published online: 13 Nov 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lan Gao, Dieu Nguyen & Peter Lee. (2022) A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia. Expert Review of Hematology 15:9, pages 833-847.
Read now
Monia Marchetti, Luca Albertin, Giulia Limberti & Manuela Canicattì. (2022) Pharmacoeconomic considerations for acute myeloid leukemia pharmacotherapy. Expert Opinion on Pharmacotherapy 23:2, pages 263-272.
Read now

Articles from other publishers (2)

Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Blanca Boluda, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Laura Torres-Miñana, Claudia Sargas, Miguel Á. Sanz, Carmela Borrell-García, Eduardo López-Briz, José Luis Poveda-Andrés, Javier De la Rubia, Pau Montesinos & David Martínez-Cuadrón. (2022) Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers 14:8, pages 1921.
Crossref
. (2019) Midostaurin in FLT3 acute myeloid leukaemia worth extra cost. PharmacoEconomics & Outcomes News 842:1, pages 18-18.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.